High-Frequency Chest-Wall Oscillation Devices Market Size, Share, Trends, Value 2030

High Frequency Chest-Wall Oscillation Devices Industry Perspective:

The global high-frequency chest-wall oscillation devices market size was USD 2458.74 million in 2022 and is expected to surpass USD 4152.36 million by the end of 2030. The market is likely to grow with a CAGR of 6.80% during the predicted period.

Request Free Sample

The global high-frequency chest-wall oscillation devices market report covers all aspects, including the potential growth drivers, restraints, and leading market players. Also, it offers detailed key insights into the opportunities and challenges in the market landscape. The report also explores market segmentation and regional developments in the high frequency chest wall oscillation devices industry.

High Frequency Chest-Wall Oscillation Devices Market: Overview

Respiration is an essential process for every living being. But the increasing pollution levels are causing the formation of mucus in the lungs. It is a very serious problem leading to other medical disorders like chronic bronchitis, bronchiectasis, cystic fibrosis, etc. Lung diseases are complex, and it highly impacts the lifestyle of patients. Medical companies have launched various devices to deal with such lung diseases. The high-frequency chest-wall oscillation device (HFCWO) is one such device that is very similar to a jacket that is easy to wear and offers relief to the patients. It is portable and easily fits to the upper part of the body. Despite the availability of several other devices, these high-frequency chest-wall oscillation devices are more in demand in the market because they offer proper support to the patients. As a result, it offers a much better lifestyle to patients for their daily work.

Key Insights

• As per the analysis shared by our research analyst, the global high frequency chest-wall oscillation devices market size is estimated to grow annually at a CAGR of around 6.80% over the forecast period (2023-2030).
• In terms of revenue, the global high frequency chest-wall oscillation devices market size was valued at around USD 2458.74 million in 2022 and is projected to reach USD 4152.36 million by 2030.
• The presence of favorable insurance coverage is likely to boost the global high frequency chest wall oscillation devices market growth during the near future.
• Based on the product, the vest type segment holds the largest share of the global market.
• Based on the distribution channel, the home setting segment accounts for the largest share of the global market.
• Based on the indication, the bronchiectasis segment dominates the global market.
• Based on region, North America is expected to dominate the market during the forecast period.

Request Free Sample

High Frequency Chest-Wall Oscillation Devices Market: Growth Drivers

Favorable insurance coverage is likely to boost the growth of the global market.

Favorable government policies and insurance coverages by big companies help people get complete treatment for a large number of respiratory diseases. Thereby, fostering growth in the global high-frequency chest-wall oscillation devices market. Also, the market for high-frequency chest-wall oscillation devices (HFCWO) is growing at a fast pace due to the constantly increasing number of patients suffering from chronic obstructive pulmonary disease. According to the British Lung Foundation, around 1.2 million people are suffering from COPD in the UK. In the US, approximately 9.3 million cases are registered for chronic bronchitis, as per the Centers for Disease Control and Prevention. These devices utilize the principles of positive and negative pressure to enhance the peripheral and tracheal mucus movements toward the airway opening. The oscillatory chest walls of the devices boost up the pressure owing to the high-frequency surpluses to the vest while it flattens when required causing an expiratory flow. Furthermore, the developments in the healthcare sector all across the globe, along with the increase in the per capita income of the people, are anticipated to propel the growth of the market exponentially in the forthcoming years. Increasing fast product approvals are another significant reason for the growth of the market.

High Frequency Chest-Wall Oscillation Devices Market: Restraints

High cost of the product is expected to restrict the growth of the global market.

The product is highly expensive, and therefore, people prefer drugs instead of HFCWO. However, it is expected to hamper the growth of the global high-frequency chest-wall oscillation devices industry in the forthcoming years.

High Frequency Chest-Wall Oscillation Devices Market: Opportunities

New product launches are likely to open lucrative growth opportunities in the global market.

Companies are boosting their research activities in order to come up with some advanced products. Also, companies have launched unique products offering more ease and comfort. Nowadays, companies are coming up with advanced charging sources for devices. Also, a few of the latest devices require less maintenance and a short period of time to charge.

High Frequency Chest-Wall Oscillation Devices Market: Challenges

Limited educational campaigns and a lack of knowledge are big challenges in the global market.

The government is making several initiatives to increase awareness among people regarding the early diagnosis and treatments of a wide variety of respiratory diseases like bronchiectasis, cystic fibrosis, COPD, etc. But the limited number of educational campaigns are not able to foster awareness among people, thereby emerging as a big challenge in the global high-frequency chest-wall oscillation devices market. Also, the lack of skilled professionals to understand and address the growing side effects of given respiratory diseases is further likely to hamper the growth of the global market.

High Frequency Chest-Wall Oscillation Devices Market: Segmentation

The global high-frequency chest-wall oscillation devices market can be segmented into product, indication, distribution channel, and region.

By product, the market can be segmented into vest type, respirtech, afflovest, and smartest. The vest-type segment holds the largest share of the global market. The vest type utilizes vibrations to loosen phlegm and mucus from the lungs. There are a variety of vest devices, like manual and automatic vests. It is majorly used for patients suffering from obstructive pulmonary disease.

By distribution channel, the market can be segmented into clinics, hospitals, home settings, and others. The home setting segment accounts for the largest share of the global high-frequency chest-wall oscillation devices industry. It helps patients recover fast and offer high independence. It offers cost-effective diagnosis, ease of comfort, and fast treatment, thereby propelling the growth of the segment.

By indication, the market can be segmented into postoperative lung transplant, pneumonia, disorders of the diaphragm, muscular dystrophy, tracheomalacia, spinal muscular atrophy, spinal cord injury, chronic bronchitis, emphysema, cerebral palsy, bronchiectasis. The bronchiectasis segment dominates the global high frequency chest wall oscillation devices industry. Bronchiectasis patients suffer from cough production and chronic sputum. It was previously defined as a rare disease, and now its diagnosis is on the global rise.

Recent Developments:

• Electromed in December 2022 revealed the clearance of Smartvest Clearway by the US FDA. This airway clearance device was made for high-frequency chest wall oscillation (''HFCWO'') therapy. It assisted the company to come up with innovative products and further offer a competitive edge over its competitors.
• Movair, in October 2022, revealed the launch of Luisa, an advanced machine suitable for use in hospitals, institutions, homes, and other portable applications for both non-invasive and invasive purposes. The launch of the product is expected to strengthen the product portfolio of the company.

High Frequency Chest Wall Oscillation Devices Market: Report Scope

High Frequency Chest-Wall Oscillation Devices Market: Regional Analysis

North America to witness the highest growth during the forecast period

North America accounts for the largest share of the global high-frequency chest-wall oscillation devices market. The major reason contributing heavily to the growth of the regional market is the fast-increasing cases of respiratory diseases. Also, the growing technological developments in the region are further anticipated to encourage the growth of the regional market. The government is making initiatives to increase awareness among people regarding early diagnosis, and complete treatment is also likely to positively impact the growth trajectory of the regional market.

Asia Pacific is also anticipated to experience significant growth in forthcoming years due to the presence of leading market players in the region. The leading market players are adopting several strategic steps to expand their distribution networks worldwide. The continuous technological developments and increasing research activities are further expected to encourage growth opportunities in the market.

Request Free Sample

Europe is also predicted to grow exponentially in the forthcoming years owing to the growing number of product approvals and increasing commercial R&D activities. Also, the companies are adopting strategic acquisition activities and collaborative research initiatives to expand the market reach in the global marketplace.

High Frequency Chest-Wall Oscillation Devices Market: Competitive Analysis

The companies in the global high-frequency chest-wall oscillation devices market are adopting several organic and inorganic strategies like acquisition, collaboration, new product launches, etc., to swipe a much larger area of market volume. The key players in the global market include:

• Aetna Inc
• Respiratory Technologies Inc.
• Hill-Rom
• International Biophysics Corporation
• Electromed Inc.

The global high frequency chest-wall oscillation devices market is segmented as follows:

By Product

• Vest Type
• Respirtech
• Afflovest
• Smartvest

By Indication

• Postoperative Lung Transplant
• Pneumonia
• Disorders Of Diaphragm
• Muscular Dystrophy
• Tracheomalacia
• Spinal Muscular Atrophy
• Spinal Cord Injury
• Chronic Bronchitis
• Emphysema
• Cerebral Palsy
• Bronchiectasis

By Distribution Channel

• Clinics
• Hospitals
• Home settings
• Others

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France 
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa